About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Enrolling By InvitationNANCT06269744

Proactive Outreach With FIT

The purpose of the study is to boost colorectal cancer (CRC) screening rates in an underserved population in Brooklyn through organized, proactive outreach of mailed Fecal Immunochemical Tests (FIT), ...

Lead sponsor: NYU Langone Health•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

NYU Langone Health

Age

45 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients
•Men and women aged 45-75
•Receiving medical care at NYULH Flatbush FHC and CHN Crown Heights, East New York, East New York Health Hub, Williamsburg clinic sites.
•Due or overdue for CRC screening.
•Medical visit of any type at clinic in past year.
•Providers
•Physicians or primary care givers at Flatbush FHC or CHN Crown Heights, East New York, East New York Health Hub, Williamsburg clinic sites (CHN employees)
•Provide care to CRC screen-eligible patients

Exclusion Criteria

•Age younger than 45 years old or greater than 75 years old
•Up-to-date with colorectal cancer screening:
•History of colorectal cancer, inflammatory bowel disease, colorectal polyps, or total colectomy
•In hospice care
•Patients 66 years or older living long-term in an institution or with advanced illness
•No address or phone number on file
•Providers
•No longer employed at an included clinic site

Related studies

RECRUITINGPhase 2

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

NCT07446322 · Ras-mutated Metastatic Colorectal Cancer, mCRC, and more

RECRUITINGPhase 1

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

NCT02600949 · Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, and more

RECRUITINGPhase 1/2

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264 · Cancer, Colorectal Cancer, and more

The Impact of Image-Assisted Colonoscope on Patient Experience, Physician Workload, and Examination Quality

NCT07541924 · Colorectal Cancer Screening, Colonic Polyps/Colonoscopy/Colorectal Neoplasms, and more

Assessing the Efficacy and Safety of ctDNA-driven Selection for Anti-EGFR Retreatment in a Real World Metastatic Colorectal Cancer Patients Cohort (the REalCHALLENGE Study)

NCT07536113 · Metastatic Colorectal Cancer (CRC)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 2, 2025Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

PhaseNA

Enrollment3,000

Start dateMar 2024

Last updatedDec 2, 2025

Condition

Colorectal Cancer

Locations shown

NYU Langone Health

Brooklyn, New York

Community Health Care Network of New York

Brooklyn, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 2, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions